CWI Analgesics versus Continuous Intravenous Fentanyl after Gynecological Surgery

Published On: 04 Dec, 2023 11:39 AM | Updated On: 04 Dec, 2023 11:39 AM

CWI Analgesics versus Continuous Intravenous Fentanyl after Gynecological Surgery

A new study aimed to demonstrate that continuous wound infiltration (CWI) is not inferior to continuous intravenous fentanyl (IV) in providing pain relief, and also compared the safety of the two methods. 

This prospective, single-center, two-arm, non-inferiority, randomized controlled trial that analyzed 59 patients. All participants were allotted either the CWI group or IV group. The visual analog scale (VAS), additional analgesic usage, and side effects were compared between the groups.

It was noted that the difference in the pain scores (VAS) at 24 hours between the CWI and IV groups was within an acceptable margin for non-inferiority. Additionally, the amount of fentanyl used in the CWI group was significantly lower than in the IV group at 48 hours postoperatively – suggesting an opioid-sparing effect for CWI in open gynecological surgeries. Additional analgesic use and adverse effects incidence were not significantly different between the two groups. 

Hence, CWI was found to be non-inferior to IV in terms of analgesic efficacy and demonstrated an opioid-sparing effect in the context of open gynecological surgery.

Source: Kuriyama M, Nakamura H, Tanabe S, Morikawa Y, Kaneko T, Kohyama A. BJOG: An International Journal of Obstetrics & Gynaecology. 2023 Nov;130(12):1459-65.


user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks